2026-07-24 from biomb.ca

Ottawa, July 24, 2026 – Innovative Medicines Canada (IMC) acknowledges today’s publication of the Pharmaceutical and Life Sciences Sector Task Force report by the ministers of health and industry, featuring recommendations to improve patient access to life-saving medications. Turning these recommendations into urgent action will be critical given recent global drug policy shifts triggered by U.S. most-favoured nation pricing, which are already influencing where innovative medicines are launched. 

The report represents the first public recognition of the need to address longstanding structural challenges facing Canada’s life sciences sector, including excessive red tape and the undervaluation of innovative medicines, both of which delay patient access and deter innovation and investment across the country.  

Read more here